Transaction #12522 · Form 4 · 0001193125-25-297322
ClearPoint Neuro, Inc. · Exercise / conversion · Common Stock
ClearPoint Neuro, Inc. · Transacted November 21, 2025 · Filed November 25, 2025
What does this filing report?
An SEC Form 4 filing for ClearPoint Neuro, Inc. records an exercise / conversion involving Common Stock on November 21, 2025. The reported quantity was 3,555. The filing date is November 25, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ClearPoint Neuro, Inc.
- Company CIK
- 0001285550
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 3,555
- Reported price
- 8.1
- Reference value
- 28,795.5
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 69,923
- Ownership description
- Not reported
- SEC acceptance time
- Nov 25, 2025, 4:30 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- D'Alessandro Danilo ↗
Chief Financial Officer
CIK 0001825163
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
- F2
- The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.